Hybrid Conferencee

International Conference on Viral Infection and Immune Response (ICVIIR - 27)

17th - 18th February 2027 | Hanoi, Vietnam
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 17–18 February 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 6 SDGs SDGs 3, 4, 9, 10, 11 and 17
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

17 FEB 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Viral Infectious Diseases: Pathogenesis and Treatment
    34
    Track Overview

    This track focuses on the mechanisms of viral pathogenesis and the latest advancements in treatment strategies for various viral infectious diseases. Discussions will include antiviral therapies, vaccine development, and emerging treatment modalities.

    Track 02
    Molecular Epidemiology of Viral Infections
    39
    Track Overview

    This session will explore the molecular epidemiology of viral infections, emphasizing the genetic and environmental factors influencing viral spread and evolution. Researchers will present findings on viral transmission dynamics and population genetics.

    Track 03
    Zoonotic Viral Diseases: Challenges and Solutions
    311
    Track Overview

    This track addresses the public health implications of zoonotic viral diseases, highlighting the transmission pathways from animals to humans. Participants will discuss prevention strategies, surveillance, and control measures.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Immunological Responses to Viral Infections
    34
    Track Overview

    This session will examine the human immune response to viral infections, including innate and adaptive immunity. Topics will cover immune evasion strategies employed by viruses and the implications for vaccine design.

    Track 05
    Public Health Strategies in Infectious Disease Control
    34
    Track Overview

    This track will focus on public health practices aimed at controlling viral infections, including outbreak response, vaccination campaigns, and health education. Case studies will illustrate successful interventions and challenges faced in various settings.

    Track 06
    Emerging Viral Threats: Surveillance and Response
    317
    Track Overview

    This session will highlight the importance of surveillance systems in detecting and responding to emerging viral threats. Discussions will include global collaboration, data sharing, and the role of technology in outbreak prediction.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

18 FEB 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Vaccinology: Innovations and Challenges
    34
    Track Overview

    This track will delve into the latest innovations in vaccine development for viral diseases, addressing both traditional and novel approaches. Challenges in vaccine distribution, public acceptance, and efficacy will also be discussed.

    Track 08
    Ethical Considerations in Viral Research and Public Health
    310
    Track Overview

    This session will explore the ethical implications of research and public health interventions related to viral infections. Topics will include informed consent, equity in vaccine distribution, and the balance between individual rights and community health.

    Track 09
    Viral Hemorrhagic Fevers: Clinical and Epidemiological Insights
    34
    Track Overview

    This track will focus on viral hemorrhagic fevers, examining clinical presentations, epidemiological trends, and management strategies. Experts will discuss the challenges of diagnosing and treating these severe infections.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Viral Hepatitis: Advances in Research and Treatment
    34
    Track Overview

    This session will cover the latest research on viral hepatitis, including epidemiology, pathogenesis, and treatment options. Discussions will highlight advancements in antiviral therapies and the impact of hepatitis on public health.

    Track 11
    Respiratory Viruses: Impact on Global Health
    34
    Track Overview

    This track will address the impact of respiratory viruses on global health, focusing on influenza, coronaviruses, and other respiratory pathogens. Participants will discuss prevention strategies, vaccine development, and the implications for public health policy.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities 11 Sustainable Cities and Communities 17 Partnerships for the Goals

Be Part of ICVIIR-27

Submit your research or complete your conference registration.